EUROCOMMERCIAL PROPERTIES N.V.: FIRST QUARTER RESULTS 2025

Date: 8 May 2025

Release: After closing of Euronext

Please open the following link to read the full report including annexes:

Attachment

• FULL PRESS RELEASE

You May Also Be Interested In

• AAVantgarde Presents Encouraging Clinical Data from AAVB-081 and Preclinical Data Supporting AAVB-039 at EURetina 2026
• Vaxcyte to Host Webcast and Conference Call to Present Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate
• CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases